-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 1, DuPont announced that its new DuPont Liveo medical-grade silicone adhesive production base in Cooper River, South Carolina, USA officially opened, aiming to provide better services to customers around the world
.
It is reported that DuPont's other medical and health businesses will actively expand the regional production capacity layout at the Cooper River plant, so as to provide local support to customers, ease supply pressure, and support customers to achieve growth in their respective markets
.
Eugenio Toccalino, global business director of DuPont Healthcare and Specialty Lubricants, said that the Cooper River production base will gradually bring more extrusion capacity online in the next two years to serve strategic customers in the short term, and expand production through new production in the medium term.
Liveo's customer base in the healthcare industry
.
"The investment in the Cooper River biopharmaceutical process manufacturing site is an important milestone in our growth strategy, which will support the expansion of our customers and help maintain business continuity
.
We are committed to investing in the healthcare sector, with recent expansions It also contributes to a more stable and sustainable supply of our products,
" Toccalino said
.
In 2021, DuPont expanded the Cooper River plant with the addition of MOLYKOTE specialty lubricants capacity
.
Through recent investments, DuPont will continue to increase its service to the healthcare market and its customers, providing high-quality, high-performance solutions, application and materials technology expertise, and strong regulatory support to serve healthcare market customers.
specific needs and challenges
.
Additionally, in the second half of 2022, DuPont expects to increase production capacity for biopharmaceutical silicone materials in China, specifically to serve fast-growing customers in the region
.